Clinical effect of sequential therapy with azithromycin in children mycoplasma pneumoniae pneumonia

In the present study, the clinical effect of Sequential Therapy with Azithromycin in children mycoplasma pneumoniae pneumonia is observed and analyzed. The 160 children who were diagnosed as mycoplasma pneumoniae pneumonia were selected as subjects. They were randomly divided into two groups: study group and reference group and each group with 80 cases. Among them, the children in study group were carried out sequential therapy of erythromycin and the sequential therapy of azithromycin in reference group. The overall treatment efficiency, the incidence of adverse reactions, the time of symptom recovery and hospitalization were compared between the two groups. Through comparing the efficiency of overall treatment between two groups, the study group has more significant advantages than reference group: P<0.05; through comparing the time of symptoms recovery and hospitalization, study group is significantly less than reference group: P<0.05; in addition, through comparing the incidence of adverse reactions, the difference between two groups is not obvious: P>0.05. For sequential therapy of azithromycin in children mycoplasma pneumoniae pneumonia, it can achieve good therapeutic effect and has no serious adverse reactions, which has tremendous applied values.